Form 8-K - Current report:
SEC Accession No. 0001079973-25-000336
Filing Date
2025-03-04
Accepted
2025-03-04 08:30:07
Documents
14
Period of Report
2025-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 29704
  Complete submission text file 0001079973-25-000336.txt   251799

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE scpx-20250303.xsd EX-101.SCH 3549
3 XBRL DEFINITION FILE scpx-20250303_def.xml EX-101.DEF 29986
4 XBRL LABEL FILE scpx-20250303_lab.xml EX-101.LAB 36527
5 XBRL PRESENTATION FILE scpx-20250303_pre.xml EX-101.PRE 27009
16 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5514
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 25701662
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)